Pay in 4 interest-free payments of $7.06 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
The ReCePI study is a Phase 3 clinical trial designed to evaluate the efficacy and safety of pathogen-reduced RBCs transfused for acute anemia in CVS compared to conventional RBCs, and to assess the clinical significance of treatment-emergent RBC antibodies
Electrical excitability and ion channels
CJC-1295 increases growth hormone and IGF-1 production, and its effects can last up to 72 hours, promoting long-term benefits
Particularly, peaks eluting near the API peak tail were hardly detectable with conventional SST hardware
The blend of berberine from Berberis aristata and milk thistle improves absorption and efficacy
In the tail suspension test (TST), the animals were hung on a bar for 6 minutes, and the immobility period, determined as the time displaying no motion, was recorded during the last 4 minutes
US$ 21.40
US$ 21.49
US$ 24.94
US$ 25.31
US$ 23.86
